Clinical Trials
Data provided by UCSF Profiles, powered by CTSI
| Clinical Trial | Principal Investigator | Related Conditions |
|---|---|---|
| US National OCS Liver Perfusion (OLP) Registry Study Id: NCT05940857 Start Date: - End Date: |
|
|
| EVR and EPO for Liver Transplant Tolerance Study Id: NCT06832189 Start Date: - End Date: |
|
|
| Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) Study Id: NCT06263426 Start Date: - End Date: |
|
|
| Expanding Liver Transplant Immunosuppression Minimization Via Everolimus Study Id: NCT06280950 Start Date: - End Date: |
|
|
| KIDney Injury in Times of COVID-19 (KIDCOV) Study Id: NCT04705766 Start Date: - End Date: |
|
|
| Pancreatic Islets and Parathyroid Gland Co-transplantation for Treatment of Type 1 Diabetes Study Id: NCT03977662 Start Date: - End Date: |
|
|
| Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol Study Id: NCT02402439 Start Date: - End Date: |
|
|
| Liver Transplantation With Tregs at UCSF Study Id: NCT03654040 Start Date: - End Date: |
|
|
| Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients Study Id: NCT02741323 Start Date: - End Date: |
|
|
| Sofosbuvir Based DAA Therapy in HIV/HCV Coinfected Pre or Post Liver Transplant Study Id: NCT02533934 Start Date: - End Date: |
|
|
| Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction Study Id: NCT02474199 Start Date: - End Date: |
|
|
| Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction Study Id: NCT02474199 Start Date: - End Date: |
|
|
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Study Id: NCT02188719 Start Date: - End Date: |
|
|
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation Study Id: NCT02188719 Start Date: - End Date: |
|
|
| Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant Study Id: NCT02429869 Start Date: - End Date: |
|
|
| Extended Follow-Up After Islet Transplantation in T1D Study Id: NCT01369082 Start Date: - End Date: |
|
|
| Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients Study Id: NCT00320606 Start Date: - End Date: |
|
|
| Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus Study Id: NCT00501709 Start Date: - End Date: |
|
|
| Pancreatic Islet Transplantation Into the Gastric Submucosa Study Id: NCT01571817 Start Date: - End Date: |
|
|
| Islet Transplantation in Type 1 Diabetes Study Id: NCT00434811 Start Date: - End Date: |
|
|
| Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes Study Id: NCT00434850 Start Date: - End Date: |
|
|
| Kidney and Liver Transplantation in People With HIV Study Id: NCT00074386 Start Date: - End Date: |
|